Depomed, a specialty pharmaceutical company, has hired August (Augie) Moretti as senior vice president (SVP) and chief financial officer (CFO). Moretti is an experienced senior financial executive and expert in securities law whose involvement in the biopharmaceutical industry spans more than three decades.
Moretti joins from Alexza Pharmaceuticals, where he served as CFO, SVP, general counsel and secretary. Previously, he served as CFO and general counsel of Alavita (formerly Surromed). Moretti has extensive experience with both private and public companies on issues relating to disclosure and public reporting, and public and private financings. Earlier in his career, he was a member of Heller Ehrman White & McAuliffe, where he represented a number of life science companies. Moretti holds a BA degree in Economics from Princeton University and a JD from Harvard Law School.
UK firms investment in training and development will increase, on average, by a fifth in the next year, claims Robert Half recruitment after interviewing 100 financial services (FS) executives.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.